The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK said it has given a world-first approval to Rotop's ...

The MHRA has approved the product for three clinical settings, including identifying how far high-risk prostate cancer has ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeting product authorised for use with ...

Trofolastat is a prostate-specific membrane antigen-targeting agent cleared for use with Technetium-99m for cancerous lesion ...

As with all products, the MHRA will keep its safety under close review. Prostate cancer is one of the most common cancers in ...

Transit Crime Investigation Unit detectives are investigating following a sexual assault in Dandenong last month. It is understood a 37-year-old woman was sexually assaulted when she was travelling on ...

Artificial intelligence can transform medicine in a myriad of ways, including its promise to act as a trusted diagnostic aide to busy clinicians. Over the past two years, proprietary AI models ...